Pleural effusion as a significant prognostic factor in non-small cell lung cancer.

Abstract:

UNLABELLED:In non-small cell lung cancer (NSCLC), pleural effusion is a frequently observed complication, and often provides a treatment difficulties. The aim of this study is to evaluate prognostic significance of pleural effusion in patients with NSCLC. MATERIALS AND METHODS:Seven hundred and eight untreated patients with NSCLC who were consecutively admitted to our department over a 20 year period up to December 1996, were analyzed using uni- and multivariate analyses. RESULTS:Univariate analysis showed pleural effusion to be a significant prognostic factor for NSCLC, in addition to gender, stage, performance status(PS). Multivariate analysis proved pleural effusion to be one of the significant prognostic factors, especially in patients with poor PS. CONCLUSION:Adequate palliative care to provide prolonged quality survival remains the primary goal of therapy for patients with poor performance status and pleural effusion until better treatments are developed.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Naito T,Satoh H,Ishikawa H,Yamashita YT,Kamma H,Takahashi H,Ohtsuka M,Hasegawa S

subject

Has Abstract

pub_date

1997-11-01 00:00:00

pages

4743-6

issue

6D

eissn

0250-7005

issn

1791-7530

journal_volume

17

pub_type

杂志文章
  • Experimental induction of apoptosis by a combination of etoposide and radiation treatment.

    abstract::The present study was undertaken to investigate cell death (particularly apoptosis) induced by etoposide, radiation, and both, and to examine p53 protein expression in relation to cell death. Nude mice transplanted with a human tumor (ependymoblastoma) were treated with etoposide (5-40 mg/kg) or 1-2 Gy X-ray irradiati...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Toda H,Hasegawa M,Hayakawa K,Kawashima M,Nakamura Y,Yamakawa M,Mitsuhashi N,Niibe H

    更新日期:2000-01-01 00:00:00

  • Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy.

    abstract:BACKGROUND:Chemotherapeutic anticancer properties are thought to derive from apoptosis pathway activation and/or cell division arrest, but animal models have also evidenced anti-angiogenic activity in some agents. PATIENTS AND METHODS:The impact of gemcitabine, irinotecan and oxaliplatin + 5-FU upon the serum markers ...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Bellone G,Novarino A,Chiappino I,Gramigni C,Carbone A,Addeo A,Tonel E,Bertetto O,Emanuelli G

    更新日期:2005-09-01 00:00:00

  • Effect of inhibition of the ROCK isoform on RT2 malignant glioma cells.

    abstract:BACKGROUND:Malignant glioma is one of the most intractable diseases in the human body. Rho-kinase (ROCK) is overexpressed and has been proposed as the main cause for the refractoriness of the disease. Since efficacious treatment is required, this study investigated the effect of inhibition of ROCK isoforms. MATERIALS ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Inaba N,Ishizawa S,Kimura M,Fujioka K,Watanabe M,Shibasaki T,Manome Y

    更新日期:2010-09-01 00:00:00

  • A positive correlation between neutrophils in regional lymph nodes and progression of gastric cancer.

    abstract:UNLABELLED:BACKGROND/AIM: Recent evidence indicates that inflammation is a hallmark of cancer. Tumor-associated neutrophils (TANs) contribute to tumor invasion. However, whether TANs and lymph node metastasis are related is unknown. Intranodal lymphatic vessel density (LVD) is significantly correlated with tumor progre...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tokumoto M,Tanaka H,Ohira M,Go Y,Okita Y,Sakurai K,Toyokawa T,Kubo N,Muguruma K,Maeda K,Sawada T,Hirakawa K

    更新日期:2014-12-01 00:00:00

  • R-verapamil decreases anti-estrogen resistance in a breast cancer model.

    abstract::Drug resistance eventually limits the effectiveness of antiestrogens in breast cancer treatment. Pharmacological reversal of this refractoriness has been attempted with R-Verapamil, a well tolerated calcium channel blocker. This drug significantly decreased the incidence of lung foci after intravenous seeding of the R...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kellen JA,Wong A,Georges E,Ling V

    更新日期:1991-03-01 00:00:00

  • Quality of life of recently treated patients with breast cancer.

    abstract:AIM:To investigate whether the negative quality of life result of a large randomized exercise intervention study (BREX) was due to considerable spontaneous recovery after adjuvant treatments. PATIENTS AND METHODS:The change in QoL was studied in the control patients of the BREX study (Group 1) and a group of similar f...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:

    authors: Penttinen H,Rautalin M,Roine R,Jahkola T,Kellokumpu-Lehtinen PL,Huovinen R,Kautiainen H,Järvenpää S,Hakamies-Blomqvist L,Blomqvist C,Saarto T

    更新日期:2014-03-01 00:00:00

  • Enhanced Systemic Bioavailability of Curcumin Through Transmucosal Administration of a Novel Microgranular Formulation.

    abstract:BACKGROUND/AIM:Curcumin is a promising nutraceutical for chemoprevention of head and neck squamous cell carcinoma (HNSCC). Capsular formulations of curcumin demonstrate low systemic bioavailability. We aimed to determine if curcumin levels were higher in healthy volunteers and cancer patients with microgranular curcumi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Latimer B,Ekshyyan O,Nathan N,Moore-Medlin T,Rong X,Ma X,Khandelwal A,Christy HT,Abreo F,McClure G,Vanchiere JA,Caldito G,Dugas T,McMartin K,Lian T,Mehta V,Nathan CA

    更新日期:2015-12-01 00:00:00

  • Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma.

    abstract:BACKGROUND/AIM:Gefitinib and erlotinib were shown to be particularly effective in a clinically selected subpopulation of non-small cell lung cancer patients (NSCLC): adenocarcinoma histology, non-smoking status, Asian origin and female gender have been associated with improved clinical benefit compared to the unselecte...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bonanno L,Schiavon M,Nardo G,Bertorelle R,Bonaldi L,Galligioni A,Indraccolo S,Pasello G,Rea F,Favaretto A

    更新日期:2010-12-01 00:00:00

  • Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters.

    abstract:OBJECTIVE:The expression of oestrogen and progesterone receptors in patients with adenocarcinoma of the uterine cervix was examined in order to determine their influence on prognosis and to evaluate the association between the steroid receptor expression and various clinicopathologic parameters. PATIENTS AND METHODS:O...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bodner K,Laubichler P,Kimberger O,Czerwenka K,Zeillinger R,Bodner-Adler B

    更新日期:2010-04-01 00:00:00

  • Prediction of immune surveillance responsive metastatic prostate cancer in pelvic lymph node and emergence of surveillance unresponsive/resistant metastatic cells.

    abstract:BACKGROUND:Immune cells (lymphocytes and macrophages) provide the microenvironment for immune surveillance of metastatic prostate cancer (PCa) cells in pelvic lymph nodes. We have hypothesized that degeneration and/or apoptosis of metastatic PCa cells in pelvic lymph nodes can distinguish between aggressive and non-agg...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sinha AA,Fernandes ET,Ewing SL,Wilson MJ

    更新日期:2013-09-01 00:00:00

  • Combination effect of equol and TRAIL against human cervical cancer cells.

    abstract:BACKGROUND/AIM:Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising candidate for cancer therapy due to its selective ability to induce apoptosis of cancer cells. However, some cancer cells are resistant to TRAIL. Here, we demonstrated that treatment with TRAIL, in combination with equol, sens...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kim EY,Kim AK

    更新日期:2013-03-01 00:00:00

  • Pathological aspects of prostate cancer and benign nodular hyperplasia.

    abstract::The aim of the study was to investigate tumor suppressor genes (TSGs) which play a role in the pathogenesis of prostate cancer. Additionally, different prostate tumors were immunohistochemically related to their potential precursor cells, the basal cells and the glandular secretory epithelium, which differ in their ho...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wernert N,Bieroff E,Hügel A

    更新日期:1997-07-01 00:00:00

  • The cancer problem--carcinogenesis and prevention from the viewpoint of the natural history of cancer.

    abstract::Cancer is mostly environmental in origin and therefore is theoretically preventable by control of environmental conditions. From the viewpoint of the natural history of cancer, the multi-step nature of neoplasia and the generally long latent period are stressed. The molecular biology of cancer tells us that neoplasia ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sugano H

    更新日期:1999-09-01 00:00:00

  • Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound.

    abstract:BACKGROUND:The effects of resveratrol (a natural polyphenol) on angiogenesis in rat gliomas were investigated by color Doppler ultrasound (CDUS). The correlation among the tumor growth rate, macroscopic angiogenesis measured by CDUS and microscopic angiogenesis was assessed by immunohistochemical staining. MATERIALS A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chen JC,Chen Y,Lin JH,Wu JM,Tseng SH

    更新日期:2006-03-01 00:00:00

  • Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.

    abstract:OBJECTIVE:Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are important regulators of cancer invasion and metastasis. Their associations to high-risk (HR) human papillomavirus (HPV) in cervical intra-epithelial neoplasia (CIN) and cervical cancer (CC) are unexplored and their prognostic significanc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Branca M,Ciotti M,Giorgi C,Santini D,Di Bonito L,Costa S,Benedetto A,Bonifacio D,Di Bonito P,Paba P,Accardi L,Syrjänen S,Favalli C,Syrjänen K,HPV-PathogenISS Study Group.

    更新日期:2006-03-01 00:00:00

  • Antimetastatic activity induced by Clostridium butyricum and characterization of effector cells.

    abstract::The effects of a bacterial vaccine, heat-killed Clostridium butyricum MII 588 cells, on the metastasis of B16-F10 melanoma in BDF1 mice was investigated. The vaccine stimulated natural killer (NK) cell cytotoxic activity against YAC-1 target cells, which peaked at 72 hr after the pretreatment, whereas maximum macropha...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chen HY,Wu SL,Yeh MY,Chen CF,Mikami Y,Wu JS

    更新日期:1993-01-01 00:00:00

  • The tyrosine kinase inhibitor AG490 inhibits growth of cancer cells and activates ERK in LS174T and HT-29 cells.

    abstract:BACKGROUND:The activity of tyrosine kinases, although strictly regulated in normal cells, is often disturbed in cancer cells. The inhibition of a tyrosine kinase could be a target for treating cancer. MATERIALS AND METHODS:The colon cancer cell lines LS174T and HT-29 and the lung cancer cell line NCI-H292 were used. T...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Saito K,Iwashita J,Murata J,Abe T

    更新日期:2006-03-01 00:00:00

  • Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen.

    abstract::Pallents with breast cancer exhibit an increased risk of developing cancer from other organs, a risk that might increase due to tamoxifen treatment. This drug has been found to cause activation of oestrogen receptors, leading to oestrogenic effects on the postmenopausal endometrium. We report follow-up of 94 patients ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Willén R,Lindahl B,Andolf E,Ingvar C,Liedman R,Ranstam J

    更新日期:1998-01-01 00:00:00

  • Colorectal Kaposi's sarcoma in an HIV-negative male in association with ulcerative rectocolitis: a case report.

    abstract::A rare case and the first reported in Italy of a classic form of colorectal Kaposi's sarcoma, associated with ulcerative rectocolitis, is presented. Following a total proctocolectomy, the patient was disease-free at four years. Some epidemiological risk factors such as sex, age, place of birth and both advanced malari...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Tedesco M,Benevolo M,Frezza F,Mancini R,Carone MD,Mottolese M,Cosimelli M

    更新日期:1999-07-01 00:00:00

  • Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis.

    abstract:BACKGROUND/AIM:We performed a systematic review and meta-analysis to investigate the safety of maintenance with olaparib after platinum-based chemotherapy in cancer patients. MATERIALS AND METHODS:Eligible studies included randomized controlled trials (RCTs) regarding the clinical role of olaparib maintenance therapy ...

    journal_title:Anticancer research

    pub_type: 杂志文章,meta分析

    doi:10.21873/anticanres.13989

    authors: Ricci AD,Rizzo A,Novelli M,Tavolari S,Palloni A,Tober N,Abbati F,Mollica V,DE Lorenzo S,Turchetti D,DI Marco M,Brandi G

    更新日期:2020-02-01 00:00:00

  • Surgical pathology examination of radical prostatectomy specimens. Updated protocol based on the Italian TAP study.

    abstract::Between January 1996 and June 2000, 192 men with prostate cancer underwent radical retropubic prostatectomy (RP) and bilateral pelvic node dissection in 26 centers participating in the Italian randomized prospective TAP study. The reviewing pathologist evaluated 145 RP specimens. Seventy-five cases had not been treate...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Mazzucchelli R,Montironi R,Prezioso D,Bono AV,Ferrari P,Manganelli A,Morelli P,De Vito ML,Santinelli A,Diamanti L,Lotti T,Polito M,Takeda Italian TAP Study Group.

    更新日期:2001-09-01 00:00:00

  • Gemcitabine as a radiosensitizer in undifferentiated tumors.

    abstract:BACKGROUND:Gemcitabine (dFdC) may cause radiosensitization by specific interference with homologous recombination-mediated DNA double-strand break repair. The radiosensitizing effect of dFdC might be less in normal healthy tissue and more restricted to undifferentiated tumor cells, making it a tumor-selective radiosens...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kal HB,El Sharouni SY,Barten-van Rijbroek AD

    更新日期:2006-01-01 00:00:00

  • The evaluation of MSX2 mRNA expression level in biliary brush cytological specimens.

    abstract:BACKGROUND:To distinguish cholangiocarcinoma from inflammatory disease remains difficult when stricture is present in the bile duct. Endoscopic brushing cytology is a convenient method for stricture in the bile duct, however, the diagnostic sensitivity of this method for malignancy is reported to be low (<60%). Msh hom...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ito H,Satoh K,Hamada S,Hirota M,Kanno A,Ishida K,Unno J,Masamune A,Katayose Y,Unno M,Shimosegawa T

    更新日期:2011-03-01 00:00:00

  • Selective cytotoxicity of L-glutamic acid gamma-monohydroxamate (GAH) for melanoma tumor cells.

    abstract::We have previously shown that L-glutamic acid gamma-monohydroxamate (GAH) exhibits an antitumor activity, both in vitro and in vivo. In this report we explore the selective cytotoxicity of GAH in vitro by comparing the survival of tumor and normal cells. GAH exerts an irreversible delayed effect with tumoral cells and...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Thomasset N,Chabanas A,Tournaire R,Malley S,Navarro C,Lawrence JJ,Doré JF,Vila J

    更新日期:1993-09-01 00:00:00

  • Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.

    abstract::Thalidomide was recently suggested to be angiogenesis-inhibitor following the demonstration of its activity in a rabbit cornea micropocket model. The purpose of the present study was to test its efficacy in solid tumors in mice. B16-F10 melanoma and CT-26 colon carcinoma cells were injected subcutaneously, intravenous...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gutman M,Szold A,Ravid A,Lazauskas T,Merimsky O,Klausner JM

    更新日期:1996-11-01 00:00:00

  • Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.

    abstract:BACKGROUND/AIM:Signaling regulation of myeloid zinc finger 1 (MZF1) has been implicated in the progression of many human malignancies; however, the mechanistic action of MZF1 in triple-negative breast cancer (TNBC) progression remains elusive. In this study, the aim was to investigate the molecular mechanisms of MZF1 a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13574

    authors: Yue CH,Liu JY,Chi CS,Hu CW,Tan KT,Huang FM,Pan YR,Lin KI,Lee CJ

    更新日期:2019-08-01 00:00:00

  • A phase I/II study of docetaxel and gemcitabine combination for chemotherapy-resistant ovarian cancer.

    abstract:BACKGROUND:A phase I/II study of docetaxel (DOC) and gemcitabine (GEM) combination for treatment-resistant ovarian cancer (OC) was conducted. MATERIALS AND METHODS:Eligible patients exhibited recurrent OC within 12 months after initial treatment, or after more than 2 chemotherapy regimens. Planned dose levels (DL) wer...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Itani Y,Hosokawa K,Ito K,Takeuchi S,Tabata T,Tsubamoto H,Fujita H,Akiyama M,Adachi S

    更新日期:2009-05-01 00:00:00

  • Malignant hidradenoma: a report of two cases and review of the literature.

    abstract:INTRODUCTION:Malignant tumors of the sweat glands are very rare. Clear cell hidradenoma is a lesion with histopathological features resembling those of eccrine poroma and eccrine spiradenoma. The biological behavior of the tumor is aggressive, with local recurrences reported in more than 50% of the surgically-treated c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Liapakis IE,Korkolis DP,Koutsoumbi A,Fida A,Kokkalis G,Vassilopoulos PP

    更新日期:2006-05-01 00:00:00

  • To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology.

    abstract::Combination therapies are used in the clinic to achieve cure, better efficacy and to circumvent resistant disease in patients. Initial assessment of the effect of such combinations, usually of two agents, is frequently performed using in vitro assays. In this review, we give a short summary of the types of analyses th...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.13472

    authors: El Hassouni B,Mantini G,Li Petri G,Capula M,Boyd L,Weinstein HNW,Vallés-Marti A,Kouwenhoven MCM,Giovannetti E,Westerman BA,Peters GJ,EORTC PAMM Group.

    更新日期:2019-07-01 00:00:00

  • Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer.

    abstract:BACKGROUND:Bisphosphonates (BPs) are considered the standard of care in metastatic breast cancer (MBC) patients with bone metastases. Because the survival for these patients may be prolonged compared with those patients with visceral metastases, they may be prescribed BPs for several years. The effects of this long-ter...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Simmons C,Amir E,Dranitsaris G,Clemons M,Wong B,Veith R,Cole DE

    更新日期:2009-07-01 00:00:00